Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.76 EUR | -4.97% | +2.52% | -54.14% |
May. 14 | Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment | MT |
May. 14 | Centogene N.V and Evotec SE Discovers Promising New Molecule to Treat Gaucher Disease | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.14% | 1.88B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- EVT Stock
- News Evotec SE
- Evotec CEO to Step Down in 2026; Interim Successor Appointed